• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMJ Open . Functional recovery following hospitalisation of patients diagnosed with COVID-19: a protocol for a longitudinal cohort study

tetano

Editor, Senior Moderator
BMJ Open


. 2021 Dec 13;11(12):e053021.
doi: 10.1136/bmjopen-2021-053021.
Functional recovery following hospitalisation of patients diagnosed with COVID-19: a protocol for a longitudinal cohort study




Julie C Reid[SUP] 1 [/SUP], Andrew P Costa[SUP] 2 3 4 5 6 [/SUP], MyLinh Duong[SUP] 2 [/SUP], Terence Ho[SUP] 2 [/SUP], Rebecca Kruisselbrink[SUP] 2 3 [/SUP], Parminder Raina[SUP] 4 6 [/SUP], Renata Kirkwood[SUP] 1 [/SUP], Aaron Jones[SUP] 3 4 [/SUP], Sophie Corriveau[SUP] 2 [/SUP], Lauren E Griffith[SUP] 4 [/SUP], Shariq Haider[SUP] 2 [/SUP], Maura Marcucci[SUP] 2 4 [/SUP], Maureen Markle-Reid[SUP] 4 [/SUP], Hope Morrison[SUP] 1 [/SUP], Natya Raghavan[SUP] 2 [/SUP], Connie Schumacher[SUP] 7 [/SUP], Brenda Vrkljan[SUP] 1 [/SUP], Mats Junek[SUP] 2 [/SUP], Leslie Martin[SUP] 2 [/SUP], Ameen Patel[SUP] 2 [/SUP], Carla Girolametto[SUP] 8 [/SUP], Tyler Pitre[SUP] 2 3 [/SUP], Marla K Beauchamp[SUP] 9 2 5 6 [/SUP], COREG Investigators



Affiliations

Abstract

Introduction: COVID-19 is an international public health crisis with more than 132 million infections worldwide. Beyond acute infection, emerging data indicate patients diagnosed with COVID-19 may experience persistent sequelae similar to survivors of sepsis or acute respiratory syndromes, including mobility limitations and fatigue. However, there is limited evidence on the trajectory of functional recovery in those hospitalised with COVID-19. The primary aim of the Coronavirus Registry Functional Recovery (COREG-FR) study is to understand the trajectory of functional recovery among individuals hospitalised for COVID-19 over the medium (up to 6 months) and longer term (6-12 months) that will guide clinical care and optimal management of serious COVID-19 illness and recovery.
Methods and analysis: COREG-FR is a multicentre longitudinal cohort study. We will enrol a minimum of 211 adults age 18 years and older with COVID-19 from five hospitals. Participants will be followed from admission to hospital as an inpatient, to hospital discharge, and at 3-month, 6-month, 9-month and up to 12-month post-hospital discharge. We will conduct telephone interviews at ward admission and discharge, and telephone interviews plus in-person assessments of physical function and lung function at all remaining follow-ups. Our primary outcome is the Activity Measure for Post-Acute Care mobility scale measured at all time points. We will conduct linear mixed effects regression analyses to explore determinants of functional outcomes after COVID-19 illness. Subgroup analyses based on age (≤65 vs >65 years), frailty status (Clinical Frailty Scale score ≤4 vs >5) and variants of concern will be conducted.
Ethics and dissemination: COREG-FR has been approved by Research Ethics Boards at participating sites. We will disseminate this work through peer-reviewed manuscripts, presentations at national and international meetings and through the established COREG website (www.coregontario.ca). COREG-FR is designed as a data platform for future studies evaluating COVID-19 recovery.
Trial registration number: NCT04602260; Pre-results.

Keywords: COVID-19; epidemiology; protocols & guidelines; rehabilitation medicine.
 
Back
Top Bottom